Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Trehalose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | TYR | P14679 | 1/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.50 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.50 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.50 |
| ▸ | GJA1 | P17302 | 1/20 | 0.49 |
| ▸ | GJB2 | P29033 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.48 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trehalose SCHEMBL7079380 | 1.00 | MAPT (0.56) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL15360972 | 1.00 | MAPT (0.56) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL1053867 | 1.00 | MAPT (0.56) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL295383 | 1.00 | MAPT (0.56) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL6827933 | 1.00 | MAPT (0.56) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL23029503 | 0.98 | MEN1 (0.57) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL13465987 | 0.98 | MEN1 (0.57) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL17072366 | 0.98 | MEN1 (0.57) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL14472517 | 0.98 | MEN1 (0.57) | MAPTMEN1KMT2APTPN1L3MBTL1 | |
| Trehalose SCHEMBL670041 | 0.98 | MEN1 (0.57) | MAPTMEN1KMT2APTPN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5551 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570073-B | Preparation method of silk fibroin freeze-dried spheres with controllable molecular weight | Fuxiang Sitai medical technology (Suzhou) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122056907-A | 8-O-acetylharpagoside nano composition and preparation method thereof | 济宁医学院 | 2026-05-19 | — | — | CN | claimed |
| CN-122059749-A | Biological organic enzyme targeted release fertilizer and application thereof in dynamic regulation and control of soil nutrients | 中农金瑞肥业有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026101415-A1 | PHARMACEUTICAL COMPOSITION OF ANTIBODY TO TSLP | Joint Stock Company ‘‘Biocad’’ (RU) | 2026-05-15 | — | — | WO | claimed |
| CN-122004438-A | Multi-flavor medlar health-care melon seeds and production process thereof | 宁夏宁峡家乡人食品科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029285-A | Methods of treating hypertrophic cardiomyopathy with AAV gene therapy vectors and therapeutic formulations | 迪纳柯公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4735041-A1 | STABILIZER COMPOSITION FOR IMMUNOGENIC COMPOSITIONS, STABILIZED IMMUNOGENIC COMPOSITIONS, METHODS AND APPLICATIONS THEREOF | Biological E Limited (IN) | 2026-05-06 | — | — | EP | claimed |
| US-20260115257-A1 | Dry Pharmaceutical Formulations of CNP Conjugates | ASCENDIS PHARMA GROWTH DISORDERS AS (DK) | 2026-04-30 | — | — | US | claimed |
| US-20260098247-A1 | DEVELOPMENT OF SOLID-STATE STORAGE OF COMPLEX BIOCHEMICAL SYSTEMS | CAL POLY CORP (US) | 2026-04-09 | — | — | US | claimed |
| US-5958455-A | MIXING ANHYDROUS TREHALOSE DILUENT, A DRUG AND SOLVENT FOR SUSPENSION OR DISSOLVING THE ANHYDROUS TTREHALOSE AND THE DRUG, PROCESSING TO FORM POWDER, FORMING THE TABLETS FROM THE POWDER | QUADRANT HOLDINGS CAMBRIDGE LTD (GB) | 1999-09-28 | — | — | US | claimed |
| CN-1213299-A | Solid formulations containing trehalose | QUADRANT HOLDINGS CAMBRIDGE (GB) | 1999-04-07 | — | — | CN | claimed |
| EP-0879048-A1 | SOLID FORMULATIONS CONTAINING TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1998-11-25 | — | — | EP | claimed |
| EP-0879049-A1 | PROCESS TO PREPARE SOLUBLE DELIVERY SYSTEMS USING VOLATILE SALTS | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1998-11-25 | — | — | EP | claimed |
| US-5762961-A | SOLUBLE TABLETS WITH DILUENTS AND BINDERS FORMED INTO TABLETS | QUADRANT HOLDINGS CAMBRIDGE LTD. (GB) | 1998-06-09 | — | — | US | claimed |
| WO-1997028789-A1 | PROCESS TO PREPARE SOLUBLE DELIVERY SYSTEMS USING VOLATILE SALTS | QUADRANT HOLDINGS CAMBRIDGE LTD. (GB) | 1997-08-14 | — | — | WO | claimed |
| WO-1997028788-A1 | SOLID FORMULATIONS CONTAINING TREHALOSE | QUADRANT HOLDINGS CAMBRIDGE LTD. (GB) | 1997-08-14 | — | — | WO | claimed |
| EP-0667245-A1 | Recording sheets containing alcohols and saccharides | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| US-5441644-A | Using ultrafiltration and selective concentration | AJINOMOTO CO., INC. (JP) | 1995-08-15 | — | — | US | claimed |
| EP-0609801-A1 | Method of isolation and purification of trehalose | Ajinomoto Co., Inc. (JP) | 1994-08-10 | — | — | EP | claimed |